Molderm
EU MDR 2017/745 — grafica della certificazione dei filler dermici
Home/Per i professionisti/Una base di conoscenza.
Per i professionisti / Riferimenti

Bibliografia.

L'elenco completo dei riferimenti della brochure Molderm 2026.

  1. Povolotskiy et al., 2018 – 10-year MAUDE analysis.
  2. Cohen et al., 2021 – Delayed HA filler complications.
  3. Jeong et al., 2025 – BDDE vs PEGDE toxicity study.
  4. ASDS Guidelines on Injectable Filler Complications, 2021.
  5. FDA MAUDE system documentation.
  6. American Society for Aesthetic Plastic Surgery. Quick Facts: Highlights of the ASAPS 2007 Statistics on Cosmetic Surgery. Available at: http://www.surgery.org. Accessed March 17, 2008
  7. Amin SP, Phelps RG, Goldberg DJ. (2006) Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg; 32: 1467-72.
  8. Angus JE, Affleck AG, leach IH, Millard LG. (2006) Two cases of delayed granulomatous reactions to the cosmetic filler Dermalive, a hyaluronic acid and acrylic hydrogel. Br J Dermatol. Nov;155(5):1077-8.
  9. Balazs EA, Denlinger JL (1989) Clinical uses of hyaluronan. Ciba Found Symp;143:265-75; discussion 275-80, 281-5.
  10. Balazs EA, Leshchiner E, Larsen N, Band P. (1995) Hyaluronan biomaterials: medical applications. Wise DL, editor. Handbook of biomaterials and applications. New York: Marcel Dekker Inc: 1693-1715.
  11. Balazs EA, Leshchiner EA. (1989) Hyaluronan its crosslinked derivative – hylan – and their medical applications. Inagaki H, Phillips GO, editors. Cellulosics utilization: research and rewards in cellulosics. Proceedings of Nisshinbo International Conference in Cellulosics Utilization in the Near Future;. New York: Elsevier Applied Science; 233-241.
  12. Balazs EA. (1991) Medical application of hyaluronan and its derivates. Gebelein CG, Cheng F, Yang V, editors. Cosmetic and pharmaceutical application of polymers. London. Plenum Press;.293-310.
  13. Bardazzi F, Ruffato A, Antonucci A, Balestri R, Tabanelli M. (2007) Cutaneous granulomatous reaction to injectable hyaluronic acid gel: another case. J Dermatolog Treat 18(1):59-62
  14. Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, Walker PS. (2007) Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study. Dermatol Surg Dec;33 Suppl 2:S128-35
  15. Bellman B. (2005) Immediate and delayed hypersensitivity reactions. Aesthetic Surgery Journal Volume 25, Issue 5, Sept-Oct, pages 489-491.
  16. Bergeret-Galley C, Latouche X, Illouz YG. (2001) The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesthetic Plast Surg Jul-Aug;25(4):249-55.
  17. Bosniak S, Cantisano-Zilkha M, Purewal BK, Zdinak LA. (2006) Combination therapies in oculofacial rejuvenation. Orbit Dec;25(4):319-26.
  18. Carruthers A, Carruthers J. (2007) Non-animal-based hyaluronic acid fillers: scientific and technical considerations. Plast Reconstr Surg Nov;120(6 Suppl):33S-40S
  19. Carruthers J, Klein W, Carruthers et al. (2005) Safety and Efficacy of Hyaluronic acid for Mouth Corners. Dermatol Surg 31:279-280.
  20. Centers for Disease Control prevention (CDC) Outbreak of mesotherapy assiciated skin reactions—District of Columbia-area. January-February 2005. MMWR Morb Mortal Wkly Rep 2005; 54: 1127-30.
  21. Fernandez-Acenero J, Zamora E, Borbujo J. (2001) Granulomatous Foreign Body Reaction Against Hyaluronic Acid: Report of a Case after Lip Augmentaion. Dermatol Surg 29:1225-1226.
  22. Fraser J.R.E., Laurent T.C., Engström-Laurent A. and Laurent U.G.B. (1984), Elimination of Hyaluronic Acid from the Blood Stream in the Human. Clinical and Experimental Pharmacology and Physiology, 11: 17-25.
  23. In Vivo Stimulation of De Novo Collagen Production Caused by Cross-Linked Hyaluronic Acid Dermal Filler Injections in Photodamaged Human Skin Wang F, Garza LA, Kang S, et al Arch Dermatol. 2007;143:155-163
  24. Lowe NJ, Maxwell CA, Patnaik R. (2007) Adverse reactions to dermal fillers: review. Dermatol Surg Nov;31(11 Pt 2):1616-25
  25. Lupton JR, Alster TS. (2000) Cutaneous hypersensitivity reaction to injectable hyaluronic gel. Dermatol Surg 26:135-7
  26. Moers-Carpi M, Vogt S, Santos BM et al. (2007) A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg 33 Suppl 2:S144-51
  27. Raulin C, Greve B, Hartschuh W, Soegding K. (2000) Exudative granulomatous reaction to hyaluronic acid. Contact Dermatitis 43:178-9.
  28. Rohrich RJ, Ghavami A, Crosby MA (2007) The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations. Plast Reconstr Surg Nov;120(6 Suppl):41S-54S
  29. Sidwell RU, Dhillon AP, Butler PE, Rustin MH. (2004) Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. Clin Exp Dermatol Nov;29(6):630-2.
  30. Zielke H, Wölber L, Weist L, Rzany B. (2008) Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg Mar;34(3):326-35; discussion 335. Epub 2007 Dec 20.